133 related articles for article (PubMed ID: 16741061)
21. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.
Hou Z; Sang S; You H; Lee MJ; Hong J; Chin KV; Yang CS
Cancer Res; 2005 Sep; 65(17):8049-56. PubMed ID: 16140980
[TBL] [Abstract][Full Text] [Related]
23. Green tea catechin controls apoptosis in colon cancer cells by attenuation of H2O2-stimulated COX-2 expression via the AMPK signaling pathway at low-dose H2O2.
Park IJ; Lee YK; Hwang JT; Kwon DY; Ha J; Park OJ
Ann N Y Acad Sci; 2009 Aug; 1171():538-44. PubMed ID: 19723101
[TBL] [Abstract][Full Text] [Related]
24. A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate.
Weinreb O; Amit T; Youdim MB
Free Radic Biol Med; 2007 Aug; 43(4):546-56. PubMed ID: 17640565
[TBL] [Abstract][Full Text] [Related]
25. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells.
Syed DN; Afaq F; Kweon MH; Hadi N; Bhatia N; Spiegelman VS; Mukhtar H
Oncogene; 2007 Feb; 26(5):673-82. PubMed ID: 16862172
[TBL] [Abstract][Full Text] [Related]
26. Effect of green tea and (-)-epigallocatechin gallate on ethanol-induced toxicity in HepG2 cells.
Lee SI; Kim HJ; Boo YC
Phytother Res; 2008 May; 22(5):669-74. PubMed ID: 18350509
[TBL] [Abstract][Full Text] [Related]
27. Green tea polyphenol epigallocatechin-3-gallate suppresses rat hepatic stellate cell invasion by inhibition of MMP-2 expression and its activation.
Zhen MC; Huang XH; Wang Q; Sun K; Liu YJ; Li W; Zhang LJ; Cao LQ; Chen XL
Acta Pharmacol Sin; 2006 Dec; 27(12):1600-7. PubMed ID: 17112415
[TBL] [Abstract][Full Text] [Related]
28. Medulloblastoma cell invasion is inhibited by green tea (-)epigallocatechin-3-gallate.
Pilorget A; Berthet V; Luis J; Moghrabi A; Annabi B; Béliveau R
J Cell Biochem; 2003 Nov; 90(4):745-55. PubMed ID: 14587030
[TBL] [Abstract][Full Text] [Related]
29. Green tea polyphenol (-) -epigallocatechin-3-gallate promotes the rapid protein kinase C- and proteasome-mediated degradation of Bad: implications for neuroprotection.
Kalfon L; Youdim MB; Mandel SA
J Neurochem; 2007 Feb; 100(4):992-1002. PubMed ID: 17156130
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of gap junctional intercellular communication by the green tea polyphenol (-)-epigallocatechin gallate in normal rat liver epithelial cells.
Kang NJ; Lee KM; Kim JH; Lee BK; Kwon JY; Lee KW; Lee HJ
J Agric Food Chem; 2008 Nov; 56(21):10422-7. PubMed ID: 18828601
[TBL] [Abstract][Full Text] [Related]
31. Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2.
Kino Y; Kojima F; Kiguchi K; Igarashi R; Ishizuka B; Kawai S
Prostaglandins Leukot Essent Fatty Acids; 2005 Aug; 73(2):103-11. PubMed ID: 15963707
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of the tea polyphenol, (-)-epigallocatechin gallate, on growth of cervical adenocarcinoma cell lines.
Noguchi M; Yokoyama M; Watanabe S; Uchiyama M; Nakao Y; Hara K; Iwasaka T
Cancer Lett; 2006 Mar; 234(2):135-42. PubMed ID: 15907368
[TBL] [Abstract][Full Text] [Related]
33. (-)-Epigallocatechin-3-gallate suppresses growth of AZ521 human gastric cancer cells by targeting the DEAD-box RNA helicase p68.
Tanaka T; Ishii T; Mizuno D; Mori T; Yamaji R; Nakamura Y; Kumazawa S; Nakayama T; Akagawa M
Free Radic Biol Med; 2011 May; 50(10):1324-35. PubMed ID: 21277973
[TBL] [Abstract][Full Text] [Related]
34. Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells.
Kim SJ; Jeong HJ; Lee KM; Myung NY; An NH; Yang WM; Park SK; Lee HJ; Hong SH; Kim HM; Um JY
J Nutr Biochem; 2007 Sep; 18(9):587-96. PubMed ID: 17446059
[TBL] [Abstract][Full Text] [Related]
35. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits nicotine- and estrogen-induced α9-nicotinic acetylcholine receptor upregulation in human breast cancer cells.
Tu SH; Ku CY; Ho CT; Chen CS; Huang CS; Lee CH; Chen LC; Pan MH; Chang HW; Chang CH; Chang YJ; Wei PL; Wu CH; Ho YS
Mol Nutr Food Res; 2011 Mar; 55(3):455-66. PubMed ID: 21370452
[TBL] [Abstract][Full Text] [Related]
36. Suppressive effects of tea polyphenol and conformational changes with receptor for advanced glycation end products (RAGE) expression in human hepatoma cells.
Takada M; Ku Y; Toyama H; Suzuki Y; Kuroda Y
Hepatogastroenterology; 2002; 49(46):928-31. PubMed ID: 12143244
[TBL] [Abstract][Full Text] [Related]
37. Autocrine actions of endothelin-1 as a growth factor in human ovarian carcinoma cells.
Bagnato A; Tecce R; Moretti C; Di Castro V; Spergel D; Catt KJ
Clin Cancer Res; 1995 Sep; 1(9):1059-66. PubMed ID: 9816080
[TBL] [Abstract][Full Text] [Related]
38. Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator.
Ho YC; Yang SF; Peng CY; Chou MY; Chang YC
J Oral Pathol Med; 2007 Nov; 36(10):588-93. PubMed ID: 17944751
[TBL] [Abstract][Full Text] [Related]
39. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity.
Jin YR; Im JH; Park ES; Cho MR; Han XH; Lee JJ; Lim Y; Kim TJ; Yun YP
J Cardiovasc Pharmacol; 2008 Jan; 51(1):45-54. PubMed ID: 18209568
[TBL] [Abstract][Full Text] [Related]
40. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy.
Williamson MP; McCormick TG; Nance CL; Shearer WT
J Allergy Clin Immunol; 2006 Dec; 118(6):1369-74. PubMed ID: 17157668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
